Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 13, 2025 • 5:30 AM ET

Date/Time Source News Release
03/10/2025 04:05 PM EDT GlobeNewswire CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
01/31/2025 08:00 AM EST GlobeNewswire CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference
01/29/2025 08:00 AM EST GlobeNewswire CervoMed to Present at the 8th International Lewy Body Dementia Conference
12/12/2024 07:00 AM EST GlobeNewswire CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/10/2024 07:00 AM EST GlobeNewswire CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies
11/27/2024 07:00 AM EST GlobeNewswire CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
11/13/2024 08:00 AM EST GlobeNewswire CervoMed Announces Key Senior Leadership Appointments
11/12/2024 07:00 AM EST GlobeNewswire CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
11/08/2024 09:55 AM EST GlobeNewswire CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup
11/07/2024 08:30 AM EST GlobeNewswire CervoMed to Participate in Upcoming Investor Conferences
Page

Additional News

As of March 13, 2025 • 5:30 AM ET

Date/Time Source News Release
01/10/2025 03:00 PM EST SeekingAlpha Catalyst Watch: Bank earnings, oil updates, powerhouse conferences in retail and healthcare
01/04/2025 11:00 AM EST SeekingAlpha Delta Air Lines, Albertsons Are The First Big Names To Report Results In 2025
01/03/2025 03:00 PM EST SeekingAlpha Catalyst Watch: CES, M&A votes and the Supreme Court tackles the TikTok case
12/28/2024 11:00 AM EST SeekingAlpha Investors Looking To Global PMIs As New Year Begins
12/27/2024 03:00 PM EST SeekingAlpha Catalyst Watch: Eyes on electric vehicle deliveries, retail data and housing reads
12/17/2024 06:30 AM EST KlickAnalytics Neutral Recommendation Issued On CRVO By H.C. Wainwright
12/10/2024 10:14 AM EST SeekingAlpha CervoMed stock crashes 77% on failed study for dementia drug
11/27/2024 08:43 AM EST SeekingAlpha CervoMed gains as dementia therapy granted FDA orphan tag
11/14/2024 04:39 AM EST US Earnings Reports Expected earnings - CervoMed Inc.
11/12/2024 07:26 AM EST SeekingAlpha CervoMed GAAP EPS of -$0.55 misses by $0.17, revenue of $1.94M misses by $0.3M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.